JPRN-jRCT2011210063进行中（未招募）2 期
A Phase 2, Randomized, Double-Blind, Placebo-controlled Study to Compare Efficacy and Safety of Oral Azacitidine plus Best Supportive Care versus Best Supportive Care as Maintenance Therapy in Japanese Subjects with Acute Myeloid Leukemia in Complete Remission
Hayakawa Jin0 个研究点目标入组 66 人开始时间: 2022年1月21日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 55age old 至 ot applicable（—）
- 性别
- All
入选标准
- •To evaluate the efficacy of CC-486 as maintenance therapy by using RFS in Japanese participants with more than 55 years with AML, who have achieved first CR or CRi after induction with intensive chemotherapy
- •with or without consolidation chemotherapy.
排除标准
- •To determine the effect of CC-486 as maintenance therapy on OS, time to relapse from CR/CRi, and time to discontinuation from treatment
- •To determine safety and tolerability
- •To determine PK
- •To determine the effect of CC-486 on HRQo
研究者
相似试验
进行中（未招募）
1 期
This is a Study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid TreatmentSubjects with Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid TreatmentMedDRA version: 21.0Level: PTClassification code 10036099Term: Polymyalgia rheumaticaSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2021-000648-23-DEAbbVie Deutschland GmbH & Co. KG160
招募中
1 期
ong-term safety, tolerability, and efficacy of losmapimod treatment in subjects with FSHDFacioscapulohumeral Muscular Dystrophy 1 (FSHD1)MedDRA version: 20.0Level: PTClassification code: 10064087Term: Facioscapulohumeral muscular dystrophy Class: 100000004850CTIS2024-512732-30-00Fulcrum Therapeutics Inc.80
进行中（未招募）
1 期
A study to test the safety, tolerability, biological activity, and pharmacokinetics of the drug ND-L02-s0201 compared with a placebo in patients with Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary Fibrosis (IPF)MedDRA version: 21.1Level: PTClassification code 10021240Term: Idiopathic pulmonary fibrosisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2017-004919-39-DEitto Denko Corporation120
进行中（未招募）
不适用
A study to evaluate if a new drug is effective in preventing the progression of lung fibrosisMedDRA version: 18.1Level: PTClassification code 10021240Term: Idiopathic pulmonary fibrosisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersIdiopathic pulmonary fibrosisEUCTR2012-001571-36-PLGilead Sciences, Inc.500
进行中（未招募）
1 期
A Study to Evaluate the Safety and Efficacy of Eluxadoline in Patients Age 12 to 17 Years with Irritable Bowel Syndrome with DiarrheaIrritable Bowel Syndrome withDiarrhea (IBS-D)MedDRA version: 20.1Level: PTClassification code 10023003Term: Irritable bowel syndromeSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 20.1Level: LLTClassification code 10060845Term: Diarrhea predominant irritable bowel syndromeSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2017-003770-14-BGAllergan LTD120